Condition
Localized Scleroderma
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 2 (1)
Trial Status
Completed3
Terminated1
Not Yet Recruiting1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06621628Not ApplicableCompletedPrimary
Photobiomodulation in Children With Localized Scleroderma
NCT04200755Phase 2CompletedPrimary
Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
NCT06646146Not ApplicableNot Yet Recruiting
Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia
NCT02411643Early Phase 1Terminated
Molecular Effects of Topical Calcipotriene on Morphea
NCT01697254Completed
The CARRA Registry
NCT02002897Not ApplicableUnknownPrimary
Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Showing all 6 trials